NCT02904057View on ClinicalTrials.gov

Evaluation of the MJGS Following Radiesse (+) Injection Into the Jawline

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Volume Loss of the Jawline
Interventions
DEVICE

Radiesse (+) Injectable Implant

Treated subjects will receive a maximum volume of 3.0 cc of Radiesse (+) per jawline.

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY

NCT02904057 - Evaluation of the MJGS Following Radiesse (+) Injection Into the Jawline | Biotech Hunter | Biotech Hunter